Chalmers, James D.
Chang, Anne B.
Chotirmall, Sanjay H.
Dhar, Raja
McShane, Pamela J.
Article History
First Online: 15 November 2018
Competing interests
: J.D.C. has been an investigator, advisory board member or trial steering committee member for several bronchiectasis clinical trials, including for Aradigm, Bayer, Grifols, Novartis and Zambon. He is chair of the European Bronchiectasis Registry. A.B.C. is a member of the data safety monitoring board for an unlicensed vaccine study (for GlaxoSmithKline) and an adviser for study design of an unlicensed product for cough (for Merck). She declares no financial conflicts of interest regarding the content of this manuscript. P.J.M. has served on the advisory committee to the FDA for Bayer and is an advisory board member for Aradigm, Bayer, Grifols, Hill Rom and Insmed. She declares no financial conflicts of interest regarding the content of this manuscript. S.H.C. and R.D. declare no competing interests.